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Summary
About 50% ofpatients with the polymyositis/scleroderma (PM-Scl) overlap syndrome are reported
to have autoantibodies to a nuclear/nucleolar particle termed PM-Scl. The particle is composed
of several polypeptides of which two have been identified as autoantigens. In this report, human
cDNA clone coding for the entire 75-kD autoantigen of the PM-Scl particle (PM-Scl 75) was
isolated from a MOLT-4 Agt-11 library. The deduced amino acid sequence of the cDNA clone
represented a protein of 355 amino acids and 39.2 kD; the in vitro translation product of this
cDNA migrated in sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) at
-70 kD. The aberrant migration of the polypeptide in SDS-PAGE was shown to be related
to the COOH halfthat was rich in acidic residues. Authenticity of the cDNA coding for PM-Scl
75 was shown by immunoreactivity of PM-Scl sera with in vitro translation products and
recombinant fusion proteins encoded by the cDNA. In addition, rabbit antibodies raised to
recombinant fusion protein reacted in immunofluorescence, immunoblotting, and immuno-
precipitation with the characteristic features displayed by human anti-PM-Scl sera.
utoantibodies in systemic autoimmune diseases can be
AU highly specific and can serve as diagnostic markers for
autoimmune diseases. Examples of this include the Sm system
of SLE, the nRNP system of mixed connective tissue dis-
ease, the centromere, RNA polymerase I, and U3 RNP
systems of scleroderma, and the transfer RNA synthetases
in myositis (for review see reference 1). More recently, au-
toantibodies havebeen used in the molecular cloning ofmany
autoantigens in an attempt to further define these molecules
and their association with the autoimmune response.
Autoantibodies have also become useful reagents in the study
of basic cellular functions. Anti-Sm/nRNP autoantibodies
were important in elucidating the involvement of the
Sm/nRNP particle in pre-mRNA splicing (2-4). Autoanti-
bodies to proliferating cell nuclear antigen (PCNA)t played
an important role in elucidating DNA replication involving
DNA polymerase delta (5, 6). The function of SS-B/La in
the processing of RNA polymerase III transcripts and tran-
1 Abbreviations used in this paper . Act D, actinomycin D; IVTP, in vitro
translation product; NBRF, National Biomedical Research Foundation;
PCNA, proliferating cell nuclear antigen; PM-Scl, polymyositis scleroderma;
RT, room temperature.
scription termination have been greatly aided by using human
autoantibodies (7, 8).
Autoantibodies to the PM-Scl antigen system are produced
predominantly by patients with features of scleroderma and
polymyositis. The incidence of anti-PM-Scl has been reported
to be 8% in polymyositis patients, 3% in scleroderma pa-
tients, and 50% in patients with polymyositis and scleroderma
overlap (9). Indirect immunofluorescence studies have shown
that PM-Scl autoantibodies stain predominantly the cell
nucleolus (10-12) with some weaker nucleoplasmic staining
(11) . Studies to localize the nucleolar staining pattern em-
ployed the property of actinomycin D (Act D) to segregate
nucleoli into the fibrillar and granular components (13). In
Act D-treated Vero cells, indirect immunofluorescence with
PM-Scl antibodies specifically stained the granular compo-
nent of the nucleolus (11). The location of PM-Scl in the
granular component was also confirmed by immunoelectron
microscopy using regenerating rat liver (11) .
At the molecular level, PM-Scl sera have been shown to
immunoprecipitate a complex of 11-16polypeptides ranging
in apparent molecular mass from 20 to 110 kD (11, 12, 14).
Of these polypeptides, several were reported to be phos-
phorylated (Reimer et al. [11] reports 80 and 20 kD; Gelpi
et al. [12] reports 68, 39, and 20 kD). No RNA was found
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studies, reactivity with a 110-kD antigen was reported in all
PM-Scl sera examined (12), while only some recognized an
80-kD antigen (11) . The structure and function of the PM-
Scl complex is not known, but its localization within the
granular component of the nucleolus suggests that it may
have some role in ribosome maturation and/or transport .
In this study, we report the use of human autoantibodies
in thecloningofhumancDNA encoding the75-kD autoan-
tigen (previously called 80 kD [11]) of the PM-Scl particle.
We show that the 1.6-kb cDNA encodes a 39.2-kD poly-
peptide that migrates aberrantly in SDS-PAGE and that the
COOH region of the molecule was responsible for this
phenomenon . Rabbit antibodies raised against recombinant
fusion protein displayedimmunoreactivity similar to human
PM-Scl 75 autoantibodies .
Materials and Methods
Human Serum . Eight PM-Scl sera defined by double im-
munodiffusion and indirect immunofluorescence staining pattern
and derived from patients with overlapping PM-Scl, as described
previously (9), were obtained from our laboratory serumbank . Five
disease control sera were also from the laboratory serumbank and
obtained from patients with autoantibody profiles of other
specificities . Normal control sera were from laboratory personnel .
Cell Lines.
￿
HeLa cells (ATCCCCL 2.2 ; American Type Cul-
ture Collection, Rockville,MD),MOLT-4 (human Tcell lympho-
blastic leukemia; ATCC CRL 1582), HepG2 (human hepatocel-
lular carcinoma, ATCC HB 8065), HL60 (human promyelocytic
leukemia, ATCC CCL240), and HEp-2(human epidermoid carci-
noma) cells were maintained in RPMI 1640 supplemented with
10% FCS, 2MM . L-glutamine, and 5 Ag/ml gentamicin sulfate in
a 5% C01/95% air incubator .
SDS-PAGE and Immunoblotting.
￿
Proteins were solubilized in
SDSsample buffer (625 mM Tris-HCI, pH 6.8, 5% $-ME, 2.3%
SDS, 10% glycerol) and separatedby discontinuousSDS-PAGE ac-
cording to the method of Laemmli (15) employing various per-
centage resolving gels,pH 8.8, and4% stacking gels,pH 6.6 . Elec-
trophoresis was carried out at 10-15 mA/gel through the stacking
and 20-25 mA/gel through the resolving gel . Bromophenol blue
(EM Science, Gibbstown, NJ) was included in the sample buffer
or added to the top reservoir to visualize buffer fronts.
Proteins were transferred to nitrocellulose essentially as described
by Towbin et al. (16) in transfer buffer (12.5mM Tris, 96mM gly-
cine, 20% methanol) overnight at 4°C with a constant voltage
of 7 V/cm . After transfer, nitrocellulose sheets were stained with
PonceauS(Sigma Chemical Co., St . Louis,MO)to monitor transfer
efficiency. Unbound sites on the nitrocellulose were blocked with
3% nonfat milk in PBS with 0.02% thimerosol for 1 h at room
temperature (RT) . Diluted sera were incubated with the nitrocel-
lulose for 1 h at RT followed by successive 10-min washes with
PBS, twice with PBS containing 0.05% Tween-20 (PBST), and
again with PBS to remove unboundantibody. Bound antibody was
traced by 1151-protein A (2-4 x 105 cpm; ICN Radiochemicals,
Irvine, CA) at RT for 1 h and unbound 1151-protein A removed
by washing as described above. Bound antibodies were visualized
by exposure of air-dried nitrocellulose to X-OMAT AR film
(Eastman Kodak, Co., Rochester, NY) .
Immunoprecipitation .
￿
Immunoprecipitation of ['SS]methionine-
labeled cell extract or in vitro translation products were performed
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using protein A-bound Sepharose, essentially as described (17) .
Briefly, 100 Al of10% (wt/vol) protein A-Sepharose was incubated
with 10 Al ofhuman sera and2-5 Al in vitro translation product
at 4°C for 60-90 min . After incubation, Sepharose beads were
washed five times with 1 ml of buffer C (50mM Tris-HCI, pH
7.4, 150 mM NaCI, 5 mM EDTA, 0.5% NP-40, 0.5% sodium
deoxycholate, 0.1% SDS) and resuspended in 40 PI SDS sample
buffer. Samples were analyzed by SDS-PAGE followed by autoradi-
ography.
cDNA Library Screening.
￿
Clones from a MOLT -4 Xgt-11 cDNA
library were initially selected by immunological screening as de-
scribed by Young and Davis (18) . All screening was performed on
duplicate filters and positive bacteriophages were subsequently
purified to 100% purity. Before screening the cDNA library,
anti-PM-Scl serumwas extensively adsorbed against bacterial and
wild-type Agt-11 phage to reduce background binding . Bound an-
tibodies were detected as described above for immunoblotting .
To obtain the full-lengthcDNA clone, theMOLT-4 librarywas
rescreened using the method of Benton and Davis (19) . Partially
overlapping 30-mer syntheticDNA oligonucleotides (5'-TTTT
GCAGAGTCTATAGCAAATCAAAGGAT3' and 5'-ATTTTAA-
ATGCTGTGATCCTTTGATTTGCT3') were designed based on
the 5' sequence of AM9.12 cDNA insert (see Fig. 3 A) using a
DNA synthesizer (model 380B ; Applied Biosystems Inc., Foster
City, CA) and radiolabeled with [c01P]ATP using the standard
fill-in reaction of Klenow polymerase (20) . Duplicate filters of
Xgt-11 plaques were prehybridized at 42°C overnight and hybrid-
ized with 106 cpm/ml ['1P]-oligonucleotides at 42°C, overnight .
Filters were washed at 51°C with three successive 20-min washes
in O.lx SSC, 0.1% SDS, and exposed to X-GMAT AR film .
DNA Subdoning and Sequence Determination . Recombinant
DNA samples were isolated from 100-ml cultures of X phage-
infectedE . coli LE392 cells as described by Maniatis et al . (21) .cDNA
insertswere excised from the ADNAusing EcoRl restriction sites
and subcloned into pBluescript SK-vector (pBST, Stratagene Inc.,
La Jolla, CA). PlasmidDNA was transformed into DH5tx cells
as described by Hanahan (22) . Nucleotide sequence was obtained
by the dideoxy method of Sanger et al. (23) and double-stranded
DNAsequencing by theprocedureofChen andSeeburg (24) using
T7DNApolymerase (Pharmacia Fine Chemicals, Piscataway, NJ) .
T3, T7, and additional oligonucleotide primers were synthesized
with aDNA synthesizer.
Polymerase Chain Reaction.
￿
PCRwasused to determine the size
and orientation ofcDNA inserts using methods essentially as de-
scribed in the GeneAmpDNAAmplification Reagent Kit (Perkin
ElmerCorp., Norwalk, CT) . 50- or 100-141 reaction volumes were
used and were composed of PCR buffer (10mM Tris-HCI, pH
8.3, 50 mM KCI, 1.0 MM MgCl2, 0.01% [wt/vol] gelatin),
dATP, dCTP, dGTP, dTTP to a final concentration of 200 AM
each, and PCR oligonucleotide primers each to a final concentra-
tion of0.2AM . Sample DNA was added and solutions heated to
95°Cfor5 min before briefcentrifugation, addition of2.5U am-
plitaq (rTaqDNA polymerase ; Perkin ElmerCorp .), andonedrop
paraffin oil (Perkin ElmerCorp.).DNAamplification wasperformed
usinga microcycler (EppendorfInc., Fremont, CA) with 35 cycles
of94°C,30 s ; 55°C, 30 s; 72°C, 90 s ; and a final7-min elongation
step at 72°C. Typically, 10-40% of reaction volumes were sepa-
rated on 1% agarose gels and stained with ethidium bromide to
visualize PCR products . DNA samples for PCR were obtained
from phage suspensions or bacterial colonies (25) .
Affiniq'-PurifiedAntibody .
￿
Bacterial cell extract expressing IPTG-
induced fusion protein was separated by SDS-PAGE and transferred
to nitrocellulose as described above . After incubation with primaryantibody, thin vertical strips were taken from the edges andcenter
of nitrocellulose sheet and processed with "II-protein A as de-
scribed aboveforimmunoblotting.Areason theremainingnitrocel-
lulose corresponding to thereactive siteson thestrips were excised
and used for antibody elution. Antibodies were affinity purified
from nitrocellulose filter by elution at pH 2.55. For affinity
purification ofantibody from Xgt-11 clones, confluentplates ofXgt-
11 clone M9.12 were induced to produce fusion protein with
isopropyl-S-thiogalacto-pyranoside (IPTG; Fisher Scientific, Fair
Lawn, NJ)-impregnated nitrocellulose filters. After overnight in-
cubation on the plates, the filters were blocked and probed with
primary antibody andwashed as describedabove forimmunoblot-
ting. Bound antibody was eluted with 3 ml of elution buffer (50
mM KHZPO,, pH 2.55, 0.3% nonfat milk)by rocking at RT for
5 min. The eluate was collected and the filter washed with 1 ml
elution buffer before neutralizing with 225 pl of 1 M Tris, pH
8.8. Antibodies were concentrated with Centricon 30 micro-
concentrators (Amicon Corp., Danvers, MA) and used for im-
munofluorescence and immunoblotting analysis.
Immunofluorescence
￿
Indirect immunofluorescence wasperformed
on cells grown on glass coverslips or commercial HEp-2 slides
(BION, Park Ridge, IL) with sera at 1:50 dilution in PBS for 30
min at RT. Unboundantibody wasremovedwith successive 5-min
washes ofPBS, PBST, and PBS. Humanantibody wastraced with
FITC conjugated goat anti-human Igs andmouseantibody with
rhodamine conjugated goat anti-mouse Igs (Caltag Laboratories,
So. San Francisco, CA) at 1:50 dilution in PBS. Second antibody
was applied for 30 min at RT andunbound antibody removedwith
washes as stated above. Coverslips were rinsed in water, mounted
with Fluorsave (Calbiochem-Behring Corp.) and allowed to set at
RT for 1 h before viewing by fluorescence microscopy.
Northern Analysis.
￿
Total RNAwere isolated from MOLT-4 and
HL60 cells using a340A nucleic acid extractor (Applied Biosystems).
Approximately 10 pg of RNA was separated by 1% agarose in
2.2 M formaldehyde and transferred overnight to a nylon filter
(ONCOR, Gaithersburg, MD). The filter was prehybridized at
42°C for 8 h and hybridized with 6 x 106 cpm/ml "P-labeled
cDNA fragment that wasgel-purified usingthe Genecleankit (Bio
101, La Jolla, CA). After overnight hybridization, the filter was
washed threetimesfor20 minin 0.1x SSCand0.1% SDSat 60°C,
followed by exposure to X-OMAT AR film.
RNA Transcription andIn Vitro Translation.
￿
Clones pA3.212 and
pPMSCL75 were used forin vitro transcription and translation ex-
periments. Both clones had identicalcDNA insertsbut had oppo-
site insert orientation. Clone pA3.212 utilized the T7 promoter
site oftheBluescript vector, andpPMSCL75 beingin the opposite
orientation, utilized theT3 promoter site ofBluescript vector. Full-
length transcriptionwasachieved by linearizing pA3.212 with Sad
or pPMSCL75 with XhoI and transcribing with T7 or T3 RNA
polymerase (Stratagene Inc.), respectively. Truncatedtranscripts were
obtained by using the internal restriction sites. Truncated clones
encoding residues 1-212 used DraNinearized pPMSCL75 and T3
RNA polymerase, while clones encoding residues 1-123 used
BamHI-linearized pA3.212 and T7 RNA polymerase. Typically,
1 pg of linearized plasmid DNA was used in each transcription
reaction.
RNAtranscripts were analyzed in a0.8% agarose gelcontaining
2.2 Mformaldehyde. Before in vitro translation, RNAsamples were
extracted with phenol/chloroform and precipitated with ethanol.
Typically, 1 pg of RNA was added in a 50 pl translation reaction
containing rabbit reticulocyte lysate (Promega, Madison, WI), 3sS-
methionine (Trans-31S-label, 70% methionine, 15% cysteine; ICN
Biochemicals), andRNaseblockII (Stratagene Inc.) as permanufac-
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turer's instructions. Translation were carried out at 30°C for 1 h
followed by 10% SDS-PAGE of a 5-10 pl aliquot to confirmpres-
ence of translation products. Samples were stored at -80°C until
required.
Fusion ProteinProduction.
￿
Expression plasmidORF75 containing
full-length PM-Scl 75 was constructed using PCR amplification
of the open reading frame of pA3.212. Synthetic oligonucleotide
primers spanning the initiation and termination sequences of
pA3.212 were constructed. The primer spanning the start codon
was 5'-GGGAATPCACAGATGGCCGCTCCAGCT3, whichcon-
tained an EcoRI restriction site (underlined), and the 3' primer
was5'-CCCTCGAGCTTTAATTGGAGCTCTC-3, with a XhoI
restriction site (underlined). The PCRproduct was purified from
a 0.8% low melting agarose gel, digested with EcoRl and Xhol
restriction enzymes, subcloned into the EcoRI and Xhol sites of
pBST, and transformed into DH5a cells. Resulting clones were
screened forinsert size andorientation usingPCR andtheselected
clones sequenced across the polylinker arms to confirm sequence
identity with parental pA3.212. Thus, pORF75 fusion protein con-
sisted of 38 residues of(3-galactosidase from the Bluescript vector,
an extra serine and glutamine introduced during the subcloning
step and the 355 amino acids that encoded for PM-Sc175. Fusion
protein was prepared from p0RF75/DH5a cultures grown to
OD6w = 0.6 and induced with IPTG added at a final concentra-
tion of 10 mM. Bacteria were harvested by centrifugation and
directly solubilized in SDS sample buffer. Proteins were separated
by SDS-PAGE and stained with Coomassieblue or transferred to
nitrocellulose forsubsequent immunoblotting experiments. Forim-
munization of experimental rabbits, recombinant fusion protein
wasenriched by the procedureof Adam et al. (26). The final pellet
ofinclusionbodies wasextracted with 8 M urea on ice for 15 min
and the supernatant stored at -70°C.
Rabbit Immunization.
￿
Two female New Zealand Whiterabbits
were immunized with 2.5 mg of fusion protein in CFA. Rabbits
were boosted twice with a further 2.5 mg fusion protein in IFA
at 30-d intervals. Serumsampleswere collected andstored at -20°C.
ComputerAnalysis ofNucleicAcid andProtein Sequences.
￿
Nucleic
acid andprotein sequenceswere analyzed by theUniversity ofWis-
consin Genetic Computer Group Sequence Analysis Software
Package(version 6.2) (27). Data basessearched were Genebank (re-
lease 65.0), EMBL (release 24.0), National Biomedical Research
Foundation (NBRF), Nucleicacid (release 36.0), and NBRF Pro-
tein (release 25.0).
Results
Immunoblotting.
￿
Screeningofeight PM-Scl sera by immu-
noblotting of MOLT -4 cell extract revealed reactivity with
two antigens of 75 and 110kD (Fig. 1). Reactivity with the
75-kD antigen was observed in two of eight sera (lanes 1
and 2) and with the 110-kD antigen in four of eight sera
(lanes 2, 4, 6, and 8). One serum displayed clear preference
for the 75-kD antigen with a weak 110-kD reactivity (lane
1), a single serum displayedequal reactivity with the 75- and
110-kD antigens (lane 2), and all other positive reactivities
were with the 110-kD antigen. Similar reactivities with the
75- and 110-kD antigens were also observed in HeLa and
HepG2 cellular extracts.
Reactivity with an additional 80-kD antigen of MOLT-4
cellswas occasionally observed with PM-Scl sera positive for
antibody to the 75-kD antigen (not reproduced in Fig. 1,
butseeFig. 2). The 80-kD antigen appeared to be cell growthFigure 1 .
￿
Immunoblotting profile of PM-Scl sera . MOLT-4 whole cell
extract was separatedby SDS-PAGE, transferred to nitrocellulose, and probed
with sera at a dilution of 1:100 . Lanes 1-8 show reactivity with PM-Scl
sera, and lane 9 shows reactivity with normal control serum. Reactive
bands common to normalcontrol serum and PM-Scl sera were nonspecific
reactivity. Arrows at left hand edge indicate position of 110- and 75-kD
PM-Scl antigens . Molecular mass markers are indicated at right hand edge.
associated, in that MOLT-4 cells examined in log phase of
growth displayed the 80-kD antigen, with much weaker re-
activity observed when cells were not dividing . Reactivity
with the 80-kD antigen was always weaker than the 75-kD
reactivity and never observed alone. The association or rela-
tionship of the 75- and 80-kD antigens was not addressed
from these data and will be the subject of future study .
Earlier immunoblotting studies from this laboratory ini-
tially assigned 80-kD to an antigenic polypeptide of PM-Scl
(11) . From our present immunoblotting data, we believe the
molecular mass of the two antigens of PM-Scl are more ac-
curately described as 110 and 75 kD . The 110-kD molecular
mass estimate is in agreement with the recent observations
of Gelpi et al. (12) . It is possible that the previously reported
80-kD reactivity (11) is identical to the 80-kD reactivity we
observed with log phase MOLT-4 cells, but this seems un-
likely since the 80-kD band was never observed without 75-
kD reactivity and was not the major reactivity in this region .
Cloning and Sequencing ofPM-SclcDNA .
￿
Human serum
Lea (Fig. 1, lane 1), reactive predominantly with the 75-kD
antigen of PM-Scl, was chosen to screen a MOLT-4 Xgt-11
expression library. From screening 970,000 plaques, 11 posi-
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tive signals were obtained, four ofwhich retained specificity
after secondary and tertiary screening to 100% purity. Insert
size ofXM4.23 was found to be 600 by and those of clones
XM4.62, XM9.12, andXM10.61, were all 700 bp. ThecDNA
inserts were subcloned into Bluescript plasmid, sequenced
across the polylinker arms, and found to represent one se-
quence, with all containing a poly-A tail . The sequence was
used to search the Genebank, EMBL, and NBRF data banks
for homologous sequences, with no close similarity found
with any reported sequences, implying our clone was new
and unique .
The cDNA inserts in X clones were shown to code for
a portion of the 75-kD antigen by affinity purification ofan-
tibody from IPTG-induced fusion protein ofXM9.12. Using
a selected PM-Scl serum containing reactivity with both the
75 and 100-kD antigens (Fig. 2 A, lane 1), adsorption against
XM9.12 fusion protein selectively removed the 75-kD reac-
tivity from the serum but not the 100-kD reactivity (Fig.
2 A, lane 2) . The complete adsorption of 75-kD reactivity
from the serum suggested that the major autoepitope(s) was
located within the sequence of the polypeptide encoded by
XM9.12 . Reactivity with the 75-kD antigen was subsequently
found in the affinity-purified antibodies from the XM9.12 fu-
sion protein (Fig. 2 A, lane 3) . The fact that the eluted anti-
bodies from the recombinant fusion protein were also able
to identify the 80-kD antigen suggested that the 75- and 80-
kD polypeptides may share antigenic determinants. These
eluted antibodies were further shown to recognize the
nucleolus and nucleoplasm of HEp-2 cells by indirect im-
munofluorescence (Fig. 2 C) in a pattern similar to that pro-
duced by whole PM-Scl serum (Fig . 2 B) .
Further screening of 100,000 plaques from the MOLT-4
Agt-11 library with [12P]-labeled synthetic oligonucleotide
corresponding to the 5' end of pM9.12 cDNA resulted in
isolation of 12 positive plaques ofwhich nine remained posi-
tive through subsequent screening . From this group, AA3.21
with an insert of -1.6 kb was subcloned into Bluescript
(pA3.212) and its sequence was subsequently determined in
both directions. The sequence strategy is illustrated in Fig .
3 A . Clone pA3.212 was composed of a 419-nucleotide 5'
untranslated region, 1,065 nucleotides of coding sequence,
and 78 nucleotides of 3' untranslated sequence. The com-
plete nucleotide and deduced amino acid sequence is shown
in Fig. 3 B . The sequence contained a Kozak consensus se-
quence (28, 29) at the ATG start codon and an ATTAAA
polyadenylation signal 18 nucleotides upstream from a string
of 20 As at the 3' end. The deduced amino acid sequence
consisted of 355 residues with a predicted molecular weight
of 39,190 and calculated pI of 4.8 as determined by the pro-
tein analysis programISOELECTRIC (27). From the deduced
amino acid sequence, the protein displayed a high propor-
tion of charged residues at its COOH end, with a string
of seven basic amino acids (KRRKKKR) between residues
346 and 352 that could be a nuclear or nucleolar localization
signal for the molecule (30, 31) .
Northern BlotAnalysis.
￿
ClonepA3.212 appeared to be bona
fide clone with a 5' untranslated region, a long open reading
frame and a poly-A tail . Due to the large discrepancy betweenthe predicted molecular weight and the observed molecular
mass by immunoblotting of cellular extracts, the size of the
mRNA encoding the 75-kD antigen was determined . Whole
RNA from MOLT-4 and HL60 cells were probed with
[32P]-labeled cDNA insert ofpA3 .212 . Fig. 4 shows a single
mRNA of -1.6 kb hybridized by the labeled cDNA, sug-
gesting thatpA3.212 could be encoding the full-length clone
for the "75-kD" PM-Scl antigen .
In Vitro Transcription and Translation Products.
￿
Having es-
tablished that the cDNA ofpA3.212 might probably encode
the full-length sequence for the 75-kD antigen, the in vitro
transcribed and translated products ofpA3.212 were further
analyzed (Fig. 5 A) . Three prominent products were seen,
with the largest migrating at -70 kD, and two lower mo-
lecular mass products migrating at 45 kD (possibly a dou-
blet) and 30 kD (Fig . 5 A, lane 1) . The nature of the lower
molecular mass products was unclear and might be the result
of degradation, internal start sites, or premature termination
of translation . The cellular PM-Scl 75 fromMOM cell ex-
tract was composed to the full-length in vitro translation
product and bacterial pORF75 fusion protein. SDS-PAGE
of MOLT-4 cell extract, recombinant fusion protein and
[35S]methionine labeled translation product followed by im-
munoblotting with PM-Scl sera confirmed the translation
product and fusion protein migrated with a lower molecular
mass than the native molecule (Fig. 5 B) . It is interesting
to note that the fusion protein encoding PM-Scl 75 (Fig . 5
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Figure 2 .
￿
Immunoblotting and indirect
immunofluorescence of affinity-purified an-
tibodies. Antibodies were purified from
XM9.12 fusion protein, (A) Immunoblot-
tingofPM-Scl serumcontainingreactivity
with 75- and 110-kD antigens inMOLT-4
whole cell extract (lane 1), immunoblot-
ting reactivity remaining in serum after ad-
sorption against XM9.12 fusion protein
(lane 2), immunoblotting reactivity eluted
from XM9.12 fusion protein (lane 3), and
reactivity oftheblocking solution used for
antibody dilution (lane 4) . Reactive band
at x+45kD is nonspecific reactivity. (B) In-
direct immunofluorescence ofwhole PM-
Scl serum, and (C) antibody eluted from
AM9.12 fusion protein .
B, lane 2) did not migrate at a higher molecular mass than
the in vitro translation product (Fig. 5 B, lane 3) even though
it coded an extra 30 amino acids (ti3.4 kD) derived from
a-galactosidase. The possibility of electrophoretic artifact
causing the mol wt difference between native and recombinant
proteins was eliminated by immunoblotting experiments
involving mixing of [35S]methionine-labeled translation
product andMOLT-4 cell extract . It was found that the signal
produced by [ 35S]methionine-labeled translation product was
slightly lower than the signal produced with the cell extract
after immunoblotting with PM-Scl serum (data not shown) .
The nature ofthe difference in molecular mass ofthe transla-
tion product and fusion protein with the native 75-kD antigen
is notknown at this point . It might imply post-translational
modification of the antigen . Using the glycosylation system
provided with the in vitro translation kit, we found that the
full-length translation product was not glycosylated to a higher
molecular mass (data not shown) .
The [35S]labeled in vitro translation product was immu-
noprecipitated with a panel of PM-Scl sera (Fig. 5 C, lanes
2-9), disease control sera (Fig. 5 C, lanes 10-14) and healthy
control sera (Fig . 5 C, lanes 15 and 16) . Reactivity with the
70-kD translation product was prominent with two PM-Scl
sera (Fig. 5 C, lanes 2 and 3, the same two that immuno-
blotted the 75-kD antigen in cell extracts), while the remaining
sera displaying weaker or no reactivity (Fig. 5 C) . The lower
45- and 30-kD translation products also appeared to be-419 CGACCGGCACGTTCACCCCATCCCTCAGGCTTTATTTATTTTTTTTCGACAGGTTCTTTTCAAGG
CTCCAGTCACCGCAGCAGTTGTCCATGCTGTAGTTTCCACTTTCCTGTATGGGCGGGCTGGTTAGG
ATTCCACTTTCCCCCAAGTGCTTAGCCCAGGGCCAGACAAAAAGTAGTTGCTTAAGAAATACTTGT
TGAAGGAATAAATTAATGAATGAATTTGTGCTTACAGCGGCTGGATGGCAGACAAACCTATGATTA
TAGGAACATCAGGATCTCATTTGGAACAGATTACGGATGCTGCATTGTGGAACTTGGAAAAACAAG
AGTTCTTGGACAGGTTTCCTG_TGAACTTGTGTCTCCAAAACTCAATCGGGCAACAGAAGGTATTCT
TTTTTTAACCTTGAACTCTCTCAG
1 ATGGCCGCTCCAGCTTTCGAACCTGGCAGGCAGTCAGATCTCTTGGTGAAGTTGAATCGACTCATG 66
1 M A A P A F E P G R Q S D L L V K L N R L M 22
67 GAAAGATGTCTAAGAAATTCGAAGTGTATAGACACTGAGTCTCTCTGTGTTGTTGCTGGTGAAAAG 132
23 E R C L R N S K C I D T E S L C V V A G E K 44
133 GTTTGGCAAATACGTGTAGACCTACATTTATTAAATCATGATGGAAATATTATTGATGCTGCCAGC 198
45 V W Q I R V D L H L L N H D G N I I D A A S 66
199 ATTGCTGCAATCGTGGCCTTATGTCATTTCCGAAGACCTGATGTCTCTGTCCAAGGAGATGAAGTA 264
67 I A A I V A L C H F R R P D V S V Q G D E V 88
265 ACACTGTATACACCTGAAGAGCGTGATCCTGTACCATTAAGTATCCACCACATGCCCATTTGTGTC 330
89 T L Y T P E E R D P V P L S I H H M P I C V 110
331 AGTTTTGCCTTTTTCCAGCAAGGAACATATTTATTGGTGGATCCCAATGAACGAGAAGAACGTGTG 396
III S F A F F Q Q G T Y L L V D P H E R E E R V 132
397 ATGGATGGCTTGCTGGTGATTGCCATGAACAAACATCGAGAGATTTGTACTATCCAGTCCAGTGGT 462
133 M D G L L V I A M N K H R E I C T I Q S S G 154
463 GGGATAATGCTACTAAAAGATCAAGTTCTGAGATGCAGTAAAATCGCTGGGGTGAAAGTAGCAGAA 528
155 G I M L L K D Q V L R C S K I A G V K V A E 176
529 ATTACAGAGCTAATATTGAAAGCTTTGGAGAATGACCAAAAAGTAAGGAAAGAAGGTGGAAAGTTT 594
177
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595 GGTTTTGCAGAGTCTATAGCAAATCAAAGGATCACAGCATTTAAAATGGAAAAGGCCCCTATTGAT 660
199 G F A E S I A N Q R I T A F R M E K A P I D 220
661 ACCTCGGATGTAGAAGAAAAAGCAGAAGAAATCATTGCTGAAGCAGAACCTCCTTCAGAAGTTGTT 726
221 T S D V E E K A E E I I A E A E P P S E V V 242
727 TCTACACCTGTGCTATGGACTCCTGGAACTGCCCAAATTGGAGAGGGAGTAGAAAACTCCTGGGGT 792
243 S T P V L W T P G T A Q I G E G V E N S W G 264
793 GATCTTGAAGACTCTCAGAAGGAAGATGATGAAGGCGGTGGTGATCAAGCTATCATTCTTGATGGT 858
265 D L E D S E K E D D E G G G D Q A I I L D G 286
859 ATAAAAATGGACACTGGAGTAGAAGTCTCTGATATTGGAAGCCAAGATGCTCCCATAATACTCTCA 924
287 I K M D T G V E V S D I G S Q D A P I I L S 308
925 GATAGTGAAGAAGAAGAAATGATCATTTTGGAACCAGACAAGAATCCAAAGAAAATAAGAACACAG 990
309 D S E E E E M I I L E P D K N P K K I R T Q 330
991 ACCACCAGTGCAAAACAAGAAAAAGCACCAAGTAAAAAGCCAGTGAAAAGAAGAAAAAAGAAGAGA 1056
331 T T S A K Q E K A P 5 K K P V K R R K X K R 352
1056 GCTGCCAATTAA 1068
353 A A N " 355
GCTAACAGTTGTATATCTGTATATATAACTATTAAAAGGGATATTTATTCCATTAAAAAAAAAAA
AAAAAAAAA 1143
Figure 3.
￿
Sequence ofcDNA encoding PM-Scl 75 . (A) Restriction map
and strategy for sequencingcDNA encoding PM-Scl 75 polypeptide . Se-
quencing was performed with synthetic oligonucleotides primers, and direc-
tion of sequencing is indicated by arrows. Restriction sites are A, Accl ;
B, BamHl ; D, DraI ; E, EcoRl ; H, HindIII ; S, Styl . (B) Complete nucleo-
tide and deduced amino acid sequence of PM-Scl 75 polypeptide. Under-
lined are (a) the first upstream in frame stop codon (TGA) at nucleotide
-69 ; (b) putative nuclear or nucleolar localization signal KRRKKKRA
starting at amino acid 346 ; (c) polyadenylation signalATTAAA at nucleo-
tide 1099 . Also indicated by arrowhead and arrow are positions of the
5' ends of X clones M9.12 and M4.23, respectively. These sequence data
are available from EMBL/Genbank/DDBJ under accession number M58460.
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Figure 4 .
￿
Northern blot analysis . Total RNA from MOLT-4 (1) and
HL60 (2) cells were isolated and separated by agarose gel electrophoresis,
transferred to Nylon paper, and probed with 32P-labeled pA3.212. Posi-
tion of PM-Scl 75mRNA, and 28S and 18SrRNA markers are indicated .
specifically immunoprecipitated, indicating the presence of
at least one epitope in these smaller fragments . This data sup-
ported the immunoblotting results in which only two sera
were found to react with the cellular 75-kD antigen . The
fact that the majority of the sera did not immunoprecipitate
or reacted very poorly with the in vitro translation product
suggested the absence or very low titer of antibodies to the
75-kD antigen.
Analysis ofAberrant Protein Migration inSDS-PAGE.
￿
The
predicted molecular mass of 39.2kD for the protein encoded
by the full-length clone and the observed molecular mass of
the in vitro translation product of70 kD, suggested that the
molecule had some characteristics that caused it to migrate
aberrantly by SDS-PAGE . This phenomenon has been ob-
served with other cloned polypeptides in which the highly
charged nature ofthese molecules are implicated as the prob-
able cause of the aberrant migration (see Discussion) . The
following describes the expression of truncated cDNA to
localize the region of the protein that was responsible for
the migration discrepancy .
In vitro translation product (IVTP) of truncated PM-Scl
75 cDNA encoding residues 1-212 (IVTP2) migrated at 24
kD (Fig . 6 C, lane 3), which was close to the predicted 23.5Figure 5 .
￿
In vitro transcription and translation ofpA3.212, and immu-
noprecipitation and comparison of apparent molecular mass with native
PM-Scl 75 and pORF75 fusion protein. (A) In vitro translation product
of pA3.212 linearized with Sacl restriction enzyme, transcribed with T7
RNA polymerase, and translated in vitro in a rabbit reticulocyte system
(lane 2) ; and the no RNA control translation is shown in lane 1 . The
largest translation product migrated at 70 kD with two smaller transla-
tion products also observed, migrating at 45 kD (doublet) and 30 kD.
(B) Comparison of apparent molecular mass of native PM-Scl 75 (lane
1), bacterial fusion protein ORF75 (lane 2), and in vitro translation of
full-length PM-Sc175cDNA (lane 3) . The samples were separatedby SDS-
PAGE and immunoblotted with PM-Scl serum . Reactivity seen in lanes
1 and 2 represented the signal from 1251-protein A used to trace the bound
IgG in immunoblotting, and the signal in lane 3 is from the
[35S]methionine-labeled translation product . Note the similarity in mo-
lecular mass of the reactive bands in the fusion protein extract and the
in vitro translation products . (C) Immunoprecipitation ofin vitro transla-
tion product with PM-Scl sera and control sera . Lane 1 represents the in
vitro translation product used in the immunoprecipitation. Immunopre-
cipitation ofPM-Scl sera are shown in lanes 2-9 and control immunopre-
cipitation were with sera containing auto-antibodies to U3 RNP (lane
10), Ku (lane 11), rRNP (lane 12), SS-B/La (lane 13), Sm (lane 14), and
with healthy control sera (lanes 15 and 16). Note the gel was overexposed
to detect weaker signals.
kD ; similarly, truncation to yield IVTP3 (residues 1-123)
produced a fragment that migrated at 14 kD (Fig. 6 C, lane
4), which was also very close to the predicted 13.6M The
initial clone XM9.12 (residues 196-355) was expressed as a
R-galactosidase fusion protein, FPl (Fig. 6A) . The predicted
molecular mass of FPl was 133 kD, but the observed molec-
ular mass was 160 kD in SDS-PAGE (Fig. 6 B, lane 3), a
difference of 27M Identity of FP1 as coding for the car-
boxy region of PM-Scl 75 was confirmed by immunoblot-
ting with PM-Scl sera (Fig . 6 B, lanes 4-6) and mousemAb
947
￿
Alderuccio et al .
to (3-galactosidase (Fig . 6 B, lanes 7-9) . The latter antibody
also identified (3-galactosidase present in BioRad high mo-
lecular mass standards (Fig. 6 B, lane 7) . Thus, a discrepancy
of 27 kD was observed, which to a major extent could ac-
count for the difference in molecular mass between the deduced
molecular mass of full-length PM-Scl 75 (39.2 kD) and the
apparent molecular mass of recombinant fusion protein en-
coding PM-Sc175 (70 kD) observed in SDS-PAGE . A sum-
mary of the results along with the deduced pI for the trun-
cated in vitro products are outlined in Table 1, and indicates
that the NH2 half of the polypeptide migrated as predicted
and theCOOH half of the molecule was the cause of the
aberrant migration in SDS-PAGE . The possible nature ofthe
aberrant migration could be associated in part with the highly
acidic nature of the COOH half of the molecule. Compar-
ison ofthe pI values ofIVTP2 and FPl, from Table 1, shows
that theCOOH half of PM-Scl 75 is over 2 pH units more
than the NH2 half of the molecule.
Immunoblotting ofFusion Protein.
￿
Fusion proteins derived
from full-length cDNA subcloned in plasmid pORF75 and
control plasmids were analyzed by immunoblotting using
PM-Scl and control sera. The fusion protein produced by
pORF75 was reactive with PM-Scl sera previously shown
to immunoblot the 75-kD antigen in whole cell extracts and
not with control disease serum or normal human serum (Fig .
7 A) . As with the in vitro translation product, the fusion
protein also migrated with a molecular mass lower than the
native molecule (Fig . 7 A, lane 2) . In addition, reactivity
was also seen with lower molecular mass bands that may cor-
respond to the lower molecular mass products of the full-
lengthcDNA in vitro translation. Specificity was shown using
Bluescript vector control and ABN9 clone encoding a COOH
fragment of the 60-kD SS-A/Ro autoantigen. These fusion
products were not identified by the PM-Scl serum (Fig . 7
A, lanes 3 and 4) . The SS-A/SS-B serum did not react with
pORF75 fusion protein (Fig. 7A, lane 6), but it did identify
the native SSA/SS-B polypeptides (Fig . 7 A, lane 5) and partial
SS-A/Ro fusion protein (Fig . 7A, lane 7) . The normal human
control serum did not show specific reactivity with cell ex-
tract or fusion proteins (Fig. 7 A, lanes 9-12) . The panel
of eight PM-Scl sera used inMOLT-4 immunoblotting were
subsequently used for immunoblotting of pORF75 fusion
protein . The 2 PM-Scl sera which reacted with MOLT-4 cel-
lular PM-Scl 75 (Fig . l, lanes 1 and 2), displayed strong reac-
tivity with the 70-kD fusion protein (Fig. 7 B, lanes 1 and
2) . Three additional PM-Scl sera also displayed weaker anti-70-
kD fusion protein reactivity (Fig. 7 B, lanes 3-5) . In addi-
tion, antibody eluted from the 70-kD recombinant fusion
protein was shown to immunoblot a 75-kD antigen ofMOLT-4
cell extract (Fig. 7 C, lane 2), corresponding to the same
molecular mass as the antigen recognized by PM-Scl serum
(Fig. 7 C, lane 1) . This further strengthened the argument
that the recombinant fusion protein and thuscDNA pA3.212
encoded PM-Scl 75 polypeptide.
Rabbit Antibody to Recombinant Fusion Protein.
￿
Further sup-
port for the authenticity of our cloned cDNA as coding for
PM-Sc175 was obtained by analyzing rabbit antisera raisedFigure 6 .
￿
Analysis of aberrant protein migration in SDS-PAGE. (A) Diagrammatic illustration of PM-Scl cDNA employed for in vitro translation
products or fusion protein . (B) Immunoblotting analysis of FP1 . Lanes 1, 4, and 7 were BioRad high molecular mass standards : myosin (200 kD),
(3-galactosidase (116 kD), phosphorylase B (94 kD), BSA (67 kD), and OVA (43 kD) . Lanes 2, 5, and 8 were wild-type Xgt-11 /3-galactosidase and
lanes 3, 6, and 9 were XM9.12 (FP1) fusion protein . Lanes 1-3 were stained by Coomassie blue. Lanes 4-6 and 7-9 were probed with PM-Scl serum
and mousemAb to (3-galactosidase, respectively. Positions of the 160-kD XM9.12 fusion protein and the 116-kD 0-galactosidase are indicated at right
hand edge . (C) In vitro translation products of no RNA control (lane 1), IVTP1 (lane 2), IVTP2 (lane 3), and IVTP3 (lane 4) were separated by
10-25% gradient SDS-PAGE, dried, and exposed to autoradiographic film . Arrows at right hand edge indicate position of the 70-, 45-, 30-, 24-, and
14-kD translation products. Higher molecular mass translation products observed in lanes 3 and 4 were due to incomplete restriction enzyme digestion
to generate the truncated transcripts.
againstpORF75 fusion protein . The resulting antibodies were
shown to react in a similar manner to PM-Scl sera by indirect
immunofluorescence, immunoblotting, and immunoprecip-
itation . Fig. 8 A illustrates the immunofluorescence staining
Table 1 .
￿
Deduced and Observed Molecular Mass of Defined
Regions of PM-Scl 75 Protein
' Deduced molecular mass and pI were calculated using the sequence anal-
ysis software package (49) .
t In vitro translation products were separated by SDS-PAGE and molecu-
lar mass determined from autoradiograph .
S Xgt-11 fusion protein was separated by SDS-PAGE and molecular mass
determined directly from Coomassie blue stained gel.
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pattern of PM-Scl serum (Fig. 8 A), showing the character-
istic nucleolar and nucleoplasmic staining, and the induced
nucleolar reactivity in rabbit sera (Fig . 8 C) after immuniza-
tion with recombinant fusion protein. It was difficult to assess
ifnucleoplasmic staining was present due to the inherent back-
ground staining even observed with rabbit pre-immune serum
(Fig . 8 B) . Immunoblotting ofMOLT -4 cellular extract with
rabbit antisera showed reactivities similar to that produced
by human serum (Fig . 8 D) . The rabbit antiserum reacted
specifically with the 75-kD antigen inMOLT4 extract (Fig.
8 D, lane 3) . Prebleed serum showed no reactivity with
MOLT-4 protein (Fig . 8 D, lane 2) . Finally, rabbit antiserum
was able to immunoprecipitate in vitro translation product
in an identical manner tohuman PM-Scl sera (Fig. 8 E, com-
pare lanes 3 and 4 with lane 6) .
Discussion
Cloning of Polymyositis Scleroderma Autoantigen
This work is aimed at extending the knowledge of the
autoantigen system PM-Scl . To begin analysis of this nucleolar
complex, we have cloned the full-length cDNA of the 75-
kD autoantigen identified by PM-Scl sera and named this PM-
Scl 75 . The 1.6-kb cDNA coded for a protein of 355 amino
acids with aberrant SDS-PAGE migration, which was found
to be associated with the highly charged COOH half of the
Amino Deduced SDS-PAGE
cDNA acids molecular molecular Deduced
constructs represented mass mass PI"
(kD) (kD)
IVTPlt 1-355 39.1 70 4.80
IVTP2 1-212 23.5 24 6.50
IVTP3 1-123 13.6 14 5.99
FPis 196-355 17.4 44 4.37Figure 7 .
￿
Immunoblotting analysis of fusion proteins and PM-Scl sera. (A) MOLT-4 whole cell extract (lanes 1, 5, and 9), PM-Scl 75 full-length
fusion protein derived from pORF75 (lanes 2, 6, and 10), partial SS-A/Ro fusion protein ABN9 (lanes 3, 7, and 11), and proteins from Bluescript
vector alone (lanes 4, 8, and 12) were probed with a PM-Scl serum (lanes 1-4), an anti-SS-A/SS-B serum (lanes 5-8), and a normal human serum
(lanes 9-12). PM-Scl autoantibodies reacted with the 75- and 110-kD antigens of MOLT-4 extract (lane 1) and fusion protein products of 70 and 45
kD (lane 2) . No specific reactivity was seen with the control fusion products (lanes 3 and 4) . Control serum with SS-A/SS-B autoantibodies reacted
specifically with the MOLT-4 SS-A/SS-B proteins (lane 5) and the fusion protein SS-A/Ro (lane 7) . The normal serum showed no specific reactivity
with MOLT-4 extract or fusion proteins (lanes 9-12) . (B) full-length fusion protein from pORF75 was immunoblotted with the panel ofeight PM-Scl
sera (lanes 1-8) or normal control sera (lanes 9 and 10) . Reactivity with the 70-kD fusion protein is seen in lanes 1-5. (C) Immunoblotting analysis
of affinity-purified antibodies from the 70-kD fusion protein . MOLT-4 whole cell extract was probed with a PM-Scl serum with 75-kD reactivity
(lane 1), antibody eluted from the 70-kD fusion protein (lane 2), and antibody eluted from an unrelated area of nitrocellulose (lane 3) .
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Figure 8 .
￿
Analysis ofrabbit antibodies raised
against full-length recombinant fusion protein.
Indirect immuno$uorescence on HEp-2 cells
ofhuman PM-Scl serum displaying characteristic
nucleolar/nucleoplasmic staining (A), rabbit
serum before immunization showing no reac-
tion (B), and rabbit serum after immunization
clearly showing nucleolar reactivity (C) . The
presence of nucleoplasmic associated staining
could not be confirmed due to background
staining. (D) Immunoblotting ofMOLT-4 cel-
lular extract with human PM-Scl and rabbit
sera . Samples were separated by 10% SDS-
PAGEand immunoblotted with PM-Scl serum
reactive with 110- and 75-kD antigens (lanes
1), rabbit serum beforeimmunization (lane 2)
and after immunization (lane 3) . Positions of
110- and 75-kD antigens are indicated by
arrows. (E) Immunoprecipitation of in vitro
translation products with human PM-Scl sera
(lanes 3 and 4), rabbit serum before immuni-
zation (lane 5) and after immunization (lane
6) . Lanes 1 and 2 represent translation product
alone and a no serum control immunoprecipi-
tation, respectively. Positions of translation
products are indicated by arrows .molecule. Although this study has not attempted to define
the antigenic determinants ofPM-Sc175, a region of 138 amino
acids that must contain an antigenic determinant was
identified . This was the coding region of AM4.23 initially
isolated by antibody screening of the MOLT-4 cDNA library.
Whether other antigenic sites are present on the molecule
will be examined in future studies .
Features ofPM-Scl 75 .
￿
Clone pA3.212 has many charac-
teristics of a full-length clone . It contains a 5' untranslated
region, a long open reading frame, and a 3' untranslated re-
gion with a polyA tail . Northern blot analysis provided in-
dependent evidence that themRNA and thus full-length clone
for PM-Scl 75 was ti1.6 kb . Analysis of the predicted pri-
mary structure of pA3.212 shows an area of basic residues
beginning at position 346 that may encode a nudear/nucleolar
localization signal . The string of residuesKRRKKKRA be-
tween 346 and 353 resembles the nuclear localization signal
KKKRK of SV40 large T antigen (30), and also displays
similarities with the molecular signal RKKRRQRRRA
found in the HIV tat protein (31) . Whether this region of
PM-Sc175 is actually responsible for nuclear/nucleolar local-
ization ofPM-Scl 75 will need to be confirmed experimentally.
The discrepancy between the deduced molecular mass of
the amino acid sequence ofpA3.212 at 39.2 kD and the ob-
served molecular mass of the 70-kD in vitro translation product
and fusion protein inSDS-PAGE is an interesting phenomenon .
Differences between observed and predicted molecular mass
have been documented for a number of cloned polypeptides
including the 70-kD autoantigen ofU1-snRNP (32), the cen-
tromere autoantigen CENP-B (33), SS-A/Ro (34), amphibian
N1/N2 histone binding protein (35), and amphibian nu-
cleoplasmin (36) . It is still unclear why these proteins have
an aberrant migration in SDS-PAGE, but the highly charged
nature of these proteins, especially regions of high negative
charge, are thought to interfere with SDS binding and thus
influence migration inSDS gels (33, 34, 36) . Analysis ofthe
primary structure ofPM-Scl 75 reveals that theCOON half
contains a high proportion of acidic residues . In this region,
there is a single stretch of 101 residues beginning at position
220 in which the charged amino acids are almost exclusively
acidic . The deduced pI for the COOH half of PM-Scl 75
is > 2 pH units more acidic than the NH2 half. We have
been able to separate and express the NH2 andCOOH re-
gions of PM-Scl 75 and have shown that the highly acidic
carboxy half had the ability to directly cause aberrant gel
migration .
An obvious goal in the study ofPM-Scl would be the elu-
cidation of its structure and function . The available data on
the complex, such as its localization to the granular region
of the nucleolus (11), its presence in the nucleoplasm, its ab-
sence from the cytoplasm, and the apparent migration of
nucleolar staining to the nucleoplasm after actinomycin D
treatment (12), suggest that it may be associated with
ribosomal biogenesis. This however must remain speculation
since no direct evidence associating PM-Scl with ribosomes
has been described . Previously described proteins found or
thought to be associated with pre-ribosomes include the 40-kD
protein ribocharin, which was associated with the precursor
of the large ribosomal subunit (37), a 100-kD protein with
protease activity (38), a94-kD protein localized to the dense
fibrillar component and granular region of the nucleolus (39),
and proteinB23 associated with the 55S rRNA subunit (40) .
Superficially, these polypeptides appear distinct from the PM-
Scl polypeptides but until directly examined, this must re-
main assumption .
In summary, we describe the cloning of a 1.6-kb cDNA
encoding the 75-kD polypeptide ofthe PM-Scl complex . The
molecule was found to migrate aberrantly bySDS-PAGE due
to the charged residues in its COOH portion . The recom-
binant polypeptide was found to elicit antibodies in rabbits
with characteristics ofhuman PM-Scl 75 autoantibody . The
role of PM-Scl 75 in the autoimmune response of PM-Scl
patients is unclear, but can now be examined in more detail
through the study and use of this cloned polypeptide. In ad-
dition, PM-Scl 75 is the first polypeptide cloned from the
PM-Scl particle and may aid in characterizing other compo-
nents of PM-Scl and in elucidating the structure and func-
tion of this complex .
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